The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V09 | Diagnostic radiopharmaceuticals | |
| 3 | V09B | Skeleton | |
| 4 | V09BA | Technetium (99mTc) compounds |
| Code | Title | |
|---|---|---|
| V09BA01 | Technetium (99mTc) oxidronic acid | |
| V09BA02 | Technetium (99mTc) medronic acid | |
| V09BA03 | Technetium (99mTc) pyrophosphate | |
| V09BA04 | Technetium (99mTc) butedronic acid |
| Active Ingredient | Description | |
|---|---|---|
| Technetium ⁹⁹ᵐTc medronic acid |
Technetium Tc 99m medronic acid is a pharmaceutical product used in nuclear medicine imaging. Technetium Tc 99m medronic acid may be used as a bone imaging agent to delineate areas of altered osteogenesis. It is composed of a technetium ion complexed with medronic acid, a type of bisphosphonate. |
|
| Technetium ⁹⁹ᵐTc oxidronic acid |
Technetium ⁹⁹ᵐTc oxidronic acid is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. Technetium ⁹⁹ᵐTc oxidronic acid is indicated as a skeletal imaging agent in adults and children to delineate areas of abnormal osteogenesis, such as those that occur with metastatic bone disease, Paget’s disease, arthritic disease, osteomyelitis, and fractures. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| OSTEOCIS Kit for radiopharmaceutical preparation | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
